Search results
Search for "inositol" in Full Text gives 12 result(s) in Beilstein Journal of Organic Chemistry.
A myo-inositol dehydrogenase involved in aminocyclitol biosynthesis of hygromycin A
- Michael O. Akintubosun and
- Melanie A. Higgins
Beilstein J. Org. Chem. 2024, 20, 589–596, doi:10.3762/bjoc.20.51
- aminocyclitol moieties. The biosynthesis of the aminocyclitol has been proposed to proceed through six enzymatic steps from glucose 6-phosphate through myo-inositol to the final methylenedioxy-containing aminocyclitol. Although there is some in vivo evidence for this proposed pathway, biochemical support for
- the individual enzyme activities is lacking. In this study, we verify the activity for one enzyme in this pathway. We show that Hyg17 is a myo-inositol dehydrogenase that has a unique substrate scope when compared to other myo-inositol dehydrogenases. Furthermore, we analyze sequences from the protein
- family containing Hyg17 and discuss genome mining strategies that target this protein family to identify biosynthetic clusters for natural product discovery. Keywords: aminocyclitol; biosynthesis; hygromycin A; inositol dehydrogenase; myo-inositol; Introduction Hygromycin A is a natural product that
Graphical Abstract
Figure 1: Proposed biosynthetic pathway for the aminocyclitol from hygromycin A.
Figure 2: Hyg17 activity. Reactions with Hyg17 and (a) various inositols with NAD+, (b) myo-inositol with NAD+...
Figure 3: SSN for PF01408. Clusters with characterized enzymes are shown in different colors and labeled with...
Figure 4: (a) SSN for inositol dehydrogenases. (b) Comparison of the hygromycin A (red) and hygromycin A-like...
Synthesis of ether lipids: natural compounds and analogues
- Marco Antônio G. B. Gomes,
- Alicia Bauduin,
- Chloé Le Roux,
- Romain Fouinneteau,
- Wilfried Berthe,
- Mathieu Berchel,
- Hélène Couthon and
- Paul-Alain Jaffrès
Beilstein J. Org. Chem. 2023, 19, 1299–1369, doi:10.3762/bjoc.19.96
- ) myo-inositol (20.6). The oxidation of the phosphite intermediate with m-CPBA followed by the catalytic hydrogenolysis of the benzyl protecting groups produced PIP3-PAF (20.7). 2 Edelfosine and diether analogues PAF and PAF-analogues that feature an acyl or more generally an ester group in sn-2
- ) where the molecular structure is altered. However, the incorporation of a saccharide unit or an inositol moiety is included in subsequent sections. Modulation sn-1: In 1986, Morris-Natschke et al. [129][130] reported a racemic synthesis of thioether analogues of edelfosine using thioglycerol as
Graphical Abstract
Figure 1: Chemical structure of some natural ether lipids (ELs).
Figure 2: Synthesis of lyso-PAF and PAF from 1-O-alkylglycerol [64].
Figure 3: Synthesis of lyso-PAF from 1,3-benzylideneglycerol 3.1 [69].
Figure 4: A) Synthesis of the two enantiomers of octadecylglycerol (4.6 and 4.10) from ᴅ-mannitol (4.1); B) s...
Figure 5: Four-step synthesis of PAF 5.6 from (S)-glycidol [73].
Figure 6: Synthesis of 1-O-alkylglycerol A) from solketal, B) from ᴅ- or ʟ-tartaric acid and the intermediate ...
Figure 7: Synthesis of EL building blocks starting from substituted glycidol 7.1a–c [82].
Figure 8: Synthesis of PAF 8.5 by using phosphoramidite 8.2 [86].
Figure 9: Synthesis of oleyl-PAF 9.7 from ʟ-serine [88].
Figure 10: Synthesis of racemic analogues of lyso-PAF 10.8 and PAF 10.9 featuring a phenyl group between the g...
Figure 11: Synthesis of racemic deoxy-lyso-PAF 11.7 and deoxy-PAF 11.8 [91].
Figure 12: Synthesis of racemic thio-PAF 12.8 [93].
Figure 13: Racemic synthesis of 13.6 to illustrate the modification of the glycerol backbone by adding a methy...
Figure 14: Racemic synthesis of 14.5 as an illustration of the introduction of methyl substituents on the glyc...
Figure 15: Synthesis of functionalized sn-2-acyl chains of PC-EL; A) Steglich esterification or acylation reac...
Figure 16: Synthesis of racemic mc-PAF (16.3), a carbamate analogue of PAF [102].
Figure 17: A) Synthesis of (R)-17.2 and (S)-17.6 starting from (S)-solketal (17.1); B) synthesis of N3-PAF (17...
Figure 18: Modification of the phosphocholine polar head to produce PAF analogues [81].
Figure 19: Racemic PAF analogues 19.3 and 19.5 characterized by the absence of the phosphate group [107].
Figure 20: Synthesis of PIP3-PAF (20.7) [108].
Figure 21: Large-scale synthesis of C18-edelfosine (21.8) [116].
Figure 22: Synthesis of C16-edelfosine (22.10) starting from isopropylidene-ʟ-glyceric acid methyl ester (22.1...
Figure 23: Phosphocholine moiety installation by the use of chlorophosphite 23.2 as key reagent [119].
Figure 24: Synthesis of rac-1-alkyl-2-O-methylglycerol (AMG) [120].
Figure 25: Synthesis of stereocontrolled 1-alkyl-2-O-methyl glycerol 25.9 (AMG) from dimethyl ᴅ-tartrate [81].
Figure 26: A) Racemic synthesis of thioether 26.4 [129,130], B) structure of sulfone analogue 26.5 [129].
Figure 27: Stereocontrolled synthesis of C18-edelfosine thioether analogue 27.8 [118].
Figure 28: Synthesis of thioether 28.4 that include a thiophosphate function [134].
Figure 29: Synthesis of ammonium thioether 29.4 and 29.6 [135].
Figure 30: Synthesis of the N-methylamino analogue of edelfosine 30.6 (BN52211) [138].
Figure 31: Synthesis of 1-desoxy analogues of edelfosine; A) with a saturated alkyl chain; B) synthesis of the...
Figure 32: Stereocontrolled synthesis of edelfosine analogue (S)-32.8 featuring a C18:1 lipid chain [142].
Figure 33: Synthesis of edelfosine analogues with modulation of the lipid chain; A) illustration with the synt...
Figure 34: Synthesis of phospholipid featuring a carbamate function to link the lipid chain to the glycerol un...
Figure 35: Synthesis of sesquiterpene conjugates of phospho glycero ether lipids [148].
Figure 36: Racemic synthesis of methyl-substituted glycerol analogues 36.7 and 36.10: A) synthesis of diether ...
Figure 37: Racemic synthesis of ilmofosine (37.6) [155,156].
Figure 38: A) Stereoselective synthesis of 38.5 via a stereoselective hydroboration reaction; B) synthesis of ...
Figure 39: Racemic synthesis of SRI62-834 (39.6) featuring a spiro-tetrahydrofurane heterocycle in position 2 ...
Figure 40: Racemic synthesis of edelfosine analogue 40.5 featuring an imidazole moiety in sn-2 position [160].
Figure 41: Racemic synthesis of fluorine-functionalized EL: A) Synthesis of 41.6 and B) synthesis of 41.8 [161-163].
Figure 42: A) Synthesis of the β-keto-ester 42.6 that also features a decyl linker between the phosphate and t...
Figure 43: Synthesis of phosphonate-based ether lipids; A) edelfosine phosphonate analogue 43.7 and B) thioeth...
Figure 44: Enantioselective synthesis of phosphonates 44.3 and 44.4 [171].
Figure 45: Racemic synthesis of phosphinate-based ether lipid 45.10 [172].
Figure 46: Racemic synthesis of edelfosine arsonium analogue 46.5 [173].
Figure 47: Synthesis of edelfosine dimethylammonium analogue 47.2 [118].
Figure 48: Synthesis of rac-C18-edelfosine methylammonium analogue 48.4 [176].
Figure 49: A) Synthesis of edelfosine N-methylpyrrolidinium analogue 49.2 or N-methylmorpholinium analogue 49.3...
Figure 50: A) Synthesis of edelfosine’s analogue 50.4 with a PE polar group; B) illustration of a pyridinium d...
Figure 51: A) Synthesis of 51.4 featuring a thiazolium cationic moiety; B) synthesis of thiazolium-based EL 51...
Figure 52: Synthesis of cationic ether lipids 52.3, 52.4 and 52.6 [135,183].
Figure 53: Synthesis of cationic carbamate ether lipid 53.5 [184].
Figure 54: Synthesis of cationic sulfonamide 54.5 [185].
Figure 55: Chemical structure of ONO-6240 (55.1) and SRI-63-119 (55.2).
Figure 56: Synthesis of non-ionic ether lipids 56.2–56.9 [188].
Figure 57: Synthesis of ether lipid conjugated to foscarnet 57.6 [189].
Figure 58: A) Synthesis of ether lipid conjugated to arabinofuranosylcytosine; B) synthesis of AZT conjugated ...
Figure 59: Synthesis of quercetin conjugate to edelfosine [191].
Figure 60: Synthesis of 60.8 (Glc-PAF) [194].
Figure 61: A) Synthesis of amino ether lipid 61.7 functionalized with a rhamnose unit and its amide analogue 6...
Figure 62: A) Synthesis of glucose ether lipid 62.4; B) structure of ether lipid 62.5 possessing a maltose uni...
Figure 63: A) Synthesis of glucuronic methyl ester 63.8; B) structure of cellobiose 63.9 and maltose 63.10 ana...
Figure 64: A) Synthesis of maltosyl glycerolipid 64.7; B) structure of lactose analogue 64.8 prepared followin...
Figure 65: A) Asymmetric synthesis of the aglycone moiety starting from allyl 4-methoxyphenyl ether; B) glycos...
Figure 66: A) Synthesis of ohmline possessing a lactose moiety. B) Structure of other glyco glycero lipids pre...
Figure 67: A) Synthesis of lactose-glycerol ether lipid 67.5; B) analogues possessing a maltose (67.6) or meli...
Figure 68: Synthesis of digalactosyl EL 68.6, A) by using trityl, benzyl and acetyl protecting groups, B) by u...
Figure 69: A) Synthesis of α-ohmline; B) structure of disaccharide ether lipids prepared by using similar meth...
Figure 70: Synthesis of lactose ether lipid 70.3 and its analogue 70.6 featuring a carbamate function as linke...
Figure 71: Synthesis of rhamnopyranoside diether 71.4 [196].
Figure 72: Synthesis of 1-O-hexadecyl-2-O-methyl-3-S-(α-ᴅ-1'-thioglucopyranosyl)-sn-glycerol (72.5) [225].
Figure 73: A) Preparation of lipid intermediate 73.4; B) synthesis of 2-desoxy-C-glycoside 73.10 [226].
Figure 74: Synthesis of galactose-pyridinium salt 74.3 [228].
Figure 75: Synthesis of myo-inositol derivative Ino-C2-PAF (75.10) [230].
Figure 76: A) Synthesis of myo-inositol phosphate building block 76.7; B) synthesis of myo-inositolphosphate d...
Figure 77: A) Synthesis of phosphatidyl-3-desoxy-inositol 77.4; B) synthesis of phosphono-3-desoxyinositol 77.9...
Figure 78: A) Structure of diether phosphatidyl-myo-inositol-3,4-diphosphate 78.1; B) synthesis of phosphatidy...
Figure 79: A) Synthesis of diether-phosphatidyl derivative 79.4 featuring a hydroxymethyl group in place of a ...
Figure 80: Synthesis of Glc-amine-PAF [78].
Figure 81: Synthesis of glucosamine ether lipid 81.4 and its analogues functionalized in position 3 of the ami...
Figure 82: Synthesis of fully deprotected aminoglucoside ether lipid 82.5 [246].
Figure 83: Synthesis of C-aminoglycoside 83.12 using Ramberg–Bäcklund rearrangement as a key step [250].
Figure 84: A) List of the most important glyco lipids and amino glyco lipids included in the study of Arthur a...
Figure 85: Synthesis of mannosamine ether lipid 85.6 [254].
Figure 86: A) Synthesis of glucosamine ether lipids with a non-natural ʟ-glucosamine moiety; B) synthesis of e...
Figure 87: A) Structure of the most efficient anticancer agents 87.1–87.4 featuring a diamino glyco ether lipi...
Figure 88: A) Synthesis of diamino glyco ether lipid 87.4; B) synthesis of bis-glycosylated ether lipid 88.10 [256]....
Figure 89: Synthesis of triamino ether lipid 89.4 [260].
Figure 90: Synthesis of chlorambucil conjugate 90.7 [261].
Figure 91: Three main methods for the preparation of glycerol ether lipid 91.3; A) from solketal and via a tri...
Figure 92: Four different methods for the installation of the phosphocholine polar head group; A) method using...
Figure 93: Illustration of two methods for the installation of saccharides or aminosaccharides; A) O-glycosyla...
Lectins of Mycobacterium tuberculosis – rarely studied proteins
- Katharina Kolbe,
- Sri Kumar Veleti,
- Norbert Reiling and
- Thisbe K. Lindhorst
Beilstein J. Org. Chem. 2019, 15, 1–15, doi:10.3762/bjoc.15.1
- of a phosphatidyl-myo-inositol core structure, glycosylated at the 2-position of myo-inositol [49][50][51]. The oligosaccharide of LM consists exclusively of linear (1→6)-linked and (1→2)-branched α-mannopyranosides [22], while in LAM the mannan structure is elongated by highly (1→2), (1→3) and (1→5
- the fast growing non-pathogenic species Mycobacterium smegmatis (M. smegmatis) contains inositol phosphate-capped LAM (PILAM) [54]. In addition to lipoglycans, various free, noncovalently associated glycolipids are present in the mycobacterial cell wall, such as the mycolic acid diester trehalose 6,6
- . identified several monosaccharides able to disperse mycobacterial clumps and inhibit bacterial cellular aggregation when added to pure cultures, including D-arabinose (both M. smegmatis and Mtb), D-xylose, inositol, and D-glucose (M. smegmatis only). The impact of D-glucose on M. smegmatis aggregation was
Graphical Abstract
Figure 1: Immune cells (e.g., macrophages) and epithelial cells express lectins on the cell surface (e.g., de...
Figure 2: Both mycobacteria and mammalian host cells possess unique subsets of glycosides on their cell surfa...
Figure 3: Structure of FimH CRD with a docked azobenzene mannobioside showing the aromatic aglycon and the ty...
Figure 4: Computer-based genome analysis supports the existence of mycobacterial glycan-binding proteins, whi...
Figure 5: Amino acid sequence and secondary structure alignments of Mtb proteins encoded by Rv1419 and Rv2075...
Figure 6: Recently, pili were detected on the cell surface of Mtb, which were classified as curli and type IV...
One hundred years of benzotropone chemistry
- Arif Dastan,
- Haydar Kilic and
- Nurullah Saracoglu
Beilstein J. Org. Chem. 2018, 14, 1120–1180, doi:10.3762/bjoc.14.98
- and in a number of other natural compounds that have shown a highly diverse range of biological activity [1][2][3][4][5][6][7][8][9], like the inhibitory activity of inositol monophosphatase [10][11], antitumor [12], antibiotic [12][13], and antibacterial activity [14] and lipoxygenase inhibitor
Graphical Abstract
Scheme 1: Tropone (1), tropolone (2) and their resonance structures.
Figure 1: Natural products containing a tropone nucleus.
Figure 2: Possible isomers 11–13 of benzotropone.
Scheme 2: Synthesis of benzotropones 11 and 12.
Scheme 3: Oxidation products of benzotropylium fluoroborate (16).
Scheme 4: Oxidation of 7-bromo-5H-benzo[7]annulene (22).
Scheme 5: Synthesis of 4,5-benzotropone (11) using o-phthalaldehyde (27).
Scheme 6: Synthesis of 4,5-benzotropone (11) starting from oxobenzonorbornadiene 31.
Scheme 7: Acid-catalyzed cleavage of oxo-bridge of 34.
Scheme 8: Synthesis of 4,5-benzotropone (11) from o-xylylene dibromide (38).
Scheme 9: Synthesis of 4,5-benzotropone (11) via the carbene adduct 41.
Scheme 10: Heck coupling strategy for the synthesis of 11.
Scheme 11: Synthesis of benzofulvalenes via carbonyl group of 4,5-benzotropone (11).
Figure 3: Some cycloheptatrienylium cations.
Scheme 12: Synthesis of condensation product 63 and its subsequent oxidative cyclization products.
Figure 4: A novel series of benzo[7]annulenes prepared from 4,5-benzotropone (11).
Scheme 13: Preparation of substituted benzo[7]annulene 72 using the Mukaiyama-Michael reaction.
Figure 5: Possible benzo[7]annulenylidenes 73–75.
Scheme 14: Thermal and photochemical decomposition of 7-diazo-7H-benzo[7]annulene (76) and the trapping of int...
Scheme 15: Synthesis of benzoheptafulvalene 86.
Scheme 16: Synthesis of 7-(diphenylmethylene)-7H-benzo[7]annulene (89).
Scheme 17: Reaction of 4,5-benzotropone (11) with dimethyl diazomethane.
Scheme 18: Synthesis of dihydrobenzomethoxyazocine 103.
Scheme 19: Synthesis and reducibility of benzo-homo-2-methoxyazocines.
Scheme 20: Synthesis of 4,5-benzohomotropones 104 and 115 from 4,5-benzotropones 11 and 113.
Scheme 21: A catalytic deuterogenation of 4,5-benzotropone (11) and synthesis of 5-monosubstituted benzo[7]ann...
Scheme 22: Synthesis of methyl benzo[7]annulenes 131 and 132.
Scheme 23: Ambident reactivity of halobenzo[7]annulenylium cations 133a/b.
Scheme 24: Preparation of benzo[7]annulenylidene–iron complexes 147.
Scheme 25: Synthesis of 1-ethynylbenzotropone (150) and the etheric compound 152 from 4,5-benzotropone (11) wi...
Scheme 26: Thermal decomposition of 4,5-benzotropone (11).
Scheme 27: Reaction of 4,5-benzotropone (11) with 1,2-ethanediol and 1,2-ethanedithiol.
Scheme 28: Conversions of 1-benzosuberone (162) to 2,3-benzotropone (12).
Scheme 29: Synthesis strategies for 2,3-bezotropone (12) using 1-benzosuberones.
Scheme 30: Oxidation-based synthesis of 2,3-benzotropone (12) via 1-benzosuberone (162).
Scheme 31: Synthesis of 2,3-benzotropone (12) from α-tetralone (171) via ring-expansion.
Scheme 32: Preparation of 2,3-benzotropone (12) by using of benzotropolone 174.
Figure 6: Benzoheptafulvenes as condensation products of 2,3-benzotropone (12).
Scheme 33: Conversion of 2,3-benzotropone (12) to tosylhydrazone salt 182 and gem-dichloride 187.
Figure 7: Benzohomoazocines 191–193 and benzoazocines 194–197.
Scheme 34: From 2,3-benzotropone (12) to carbonium ions 198–201.
Scheme 35: Cycloaddition reactions of 2,3-benzotropone (12).
Scheme 36: Reaction of 2,3-benzotropone (12) with various reagents and compounds.
Figure 8: 3,4-Benzotropone (13) and its resonance structure.
Scheme 37: Synthesis of 6,7-benzobicyclo[3.2.0]hepta-3,6-dien-2-one (230).
Figure 9: Photolysis and thermolysis products of 230.
Figure 10: Benzotropolones and their tautomeric structures.
Scheme 38: Synthesis strategies of 4,5-benzotropolone (238).
Scheme 39: Synthesis protocol for 2-hydroxy-4,5-benzotropone (238) using oxazole-benzo[7]annulene 247.
Figure 11: Some quinoxaline and pyrazine derivatives 254–256 prepared from 4,5-benzotropolone (238).
Scheme 40: Nitration product of 4,5-benzotropolone (238) and its isomerization to 1-nitro-naphthoic acid (259)....
Scheme 41: Synthesis protocol for 6-hydroxy-2,3-benzotropone (239) from benzosuberone (162).
Scheme 42: Various reactions via 6-hydroxy-2,3-benzotropone (239).
Scheme 43: Photoreaction of 6-hydroxy-2,3-benzotropone (239).
Scheme 44: Synthesis of 7-hydroxy-2,3-benzotropone (241) from benzosuberone (162).
Scheme 45: Synthesis strategy for 7-hydroxy-2,3-benzotropone (241) from ketone 276.
Scheme 46: Synthesis of 7-hydroxy-2,3-benzotropone (241) from β-naphthoquinone (280).
Scheme 47: Synthesis of 7-hydroxy-2,3-benzotropone (241) from bicyclic endoperoxide 213.
Scheme 48: Synthesis of 7-hydroxy-2,3-benzotropone (241) by ring-closing metathesis.
Figure 12: Various monosubstitution products 289–291 of 7-hydroxy-2,3-benzotropone (241).
Scheme 49: Reaction of 7-hydroxy-2,3-benzotropone (241) with various reagents.
Scheme 50: Synthesis of 4-hydroxy-2,3-benzotropones 174 and 304 from diketones 300/301.
Scheme 51: Catalytic hydrogenation of diketones 300 and 174.
Scheme 52: Synthesis of halo-benzotropones from alkoxy-naphthalenes 306, 307 and 310.
Figure 13: Unexpected byproducts 313–315 during synthesis of chlorobenzotropone 309.
Figure 14: Some halobenzotropones and their cycloadducts.
Scheme 53: Multisep synthesis of 2-chlorobenzotropone 309.
Scheme 54: A multistep synthesis of 2-bromo-benzotropone 26.
Scheme 55: A multistep synthesis of bromo-2,3-benzotropones 311 and 316.
Scheme 56: Oxidation reactions of 8-bromo-5H-benzo[7]annulene (329) with some oxidants.
Scheme 57: Synthesis of 2-bromo-4,5-benzotropone (26).
Scheme 58: Synthesis of 6-chloro-2,3-benzotropone (335) using LiCl and proposed intermediate 336.
Scheme 59: Reaction of 7-bromo-2,3-benzotropone (316) with methylamine.
Scheme 60: Reactions of bromo-2,3-benzotropones 26 and 311 with dimethylamine.
Scheme 61: Reactions of bromobenzotropones 311 and 26 with NaOMe.
Scheme 62: Reactions of bromobenzotropones 26 and 312 with t-BuOK in the presence of DPIBF.
Scheme 63: Cobalt-catalyzed reductive cross-couplings of 7-bromo-2,3-benzotropone (316) with cyclic α-bromo en...
Figure 15: Cycloadduct 357 and its di-π-methane rearrangement product 358.
Scheme 64: Catalytic hydrogenation of 2-chloro-4,5-benzotropone (311).
Scheme 65: Synthesis of dibromo-benzotropones from benzotropones.
Scheme 66: Bromination/dehydrobromination of benzosuberone (162).
Scheme 67: Some transformations of isomeric dibromo-benzotropones 261A/B.
Scheme 68: Transformations of benzotropolone 239B to halobenzotropolones 369–371.
Figure 16: Bromobenzotropolones 372–376 and 290 prepared via bromination/dehydrobromination strategy.
Scheme 69: Synthesis of some halobenzotropolones 289, 377 and 378.
Figure 17: Bromo-chloro-derivatives 379–381 prepared via chlorination.
Scheme 70: Synthesis of 7-iodo-3,4-benzotropolone (382).
Scheme 71: Hydrogenation of bromobenzotropolones 369 and 370.
Scheme 72: Debromination reactions of mono- and dibromides 290 and 375.
Figure 18: Nitratation and oxidation products of some halobenzotropolenes.
Scheme 73: Azo-coupling reactions of some halobenzotropolones 294, 375 and 378.
Figure 19: Four possible isomers of dibenzotropones 396–399.
Figure 20: Resonance structures of tribenzotropone (400).
Scheme 74: Two synthetic pathways for tribenzotropone (400).
Scheme 75: Synthesis of tribenzotropone (400) from dibenzotropone 399.
Scheme 76: Synthesis of tribenzotropone (400) from 9,10-phenanthraquinone (406).
Scheme 77: Synthesis of tribenzotropone (400) from trifluoromethyl-substituted arene 411.
Figure 21: Dibenzosuberone (414).
Figure 22: Reduction products 415 and 416 of tribenzotropone (400).
Figure 23: Structures of tribenzotropone dimethyl ketal 417 and 4-phenylfluorenone (412) and proposed intermed...
Figure 24: Structures of benzylidene- and methylene-9H-tribenzo[a,c,e][7]annulenes 419 and 420 and chiral phos...
Figure 25: Structures of tetracyclic alcohol 422, p-quinone methide 423 and cation 424.
Figure 26: Structures of host molecules 425–427.
Scheme 78: Synthesis of non-helical overcrowded derivatives syn/anti-431.
Figure 27: Hexabenzooctalene 432.
Figure 28: Structures of possible eight isomers 433–440 of naphthotropone.
Scheme 79: Synthesis of naphthotropone 437 starting from 1-phenylcycloheptene (441).
Scheme 80: Synthesis of 10-hydroxy-11H-cyclohepta[a]naphthalen-11-one (448) from diester 445.
Scheme 81: Synthesis of naphthotropone 433.
Scheme 82: Synthesis of naphthotropones 433 and 434 via cycloaddition reaction.
Scheme 83: Synthesis of naphthotropone 434 starting from 452.
Figure 29: Structures of tricarbonyl(tropone)irons 458, and possible cycloadducts 459.
Scheme 84: Synthesis of naphthotropone 436.
Scheme 85: Synthesis of precursor 465 for naphthotropone 435.
Scheme 86: Generation of naphthotropone 435 from 465.
Figure 30: Structures of tropylium cations 469 and 470.
Figure 31: Structures of tropylium ions 471+.BF4−, 472+.BF4−, and 473+.BF4−.
Scheme 87: Synthesis of tropylium ions 471+.BF4− and 479+.ClO4−.
Scheme 88: Synthesis of 1- and 2-methylanthracene (481 and 482) via carbene–carbene rearrangement.
Figure 32: Trapping products 488–490.
Scheme 89: Generation and chemistry of a naphthoannelated cycloheptatrienylidene-cycloheptatetraene intermedia...
Scheme 90: Proposed intermediates and reaction pathways for adduct 498.
Scheme 91: Exited-state intramolecular proton transfer of 505.
Figure 33: Benzoditropones 506 and 507.
Scheme 92: Synthesis of benzoditropone 506e.
Scheme 93: Synthetic approaches for dibenzotropone 507 via tropone (1).
Scheme 94: Formation mechanisms of benzoditropone 507 and 516 via 515.
Scheme 95: Synthesis of benzoditropones 525 and 526 from pyromellitic dianhydride (527).
Figure 34: Possible three benzocyclobutatropones 534–536.
Scheme 96: Synthesis of benzocyclobutatropones 534 and 539.
Scheme 97: Synthesis attempts for benzocyclobutatropone 545.
Scheme 98: Generation and trapping of symmetric benzocyclobutatropone 536.
Scheme 99: Synthesis of chloro-benzocyclobutatropone 552 and proposed mechanism of fluorenone derivatives.
Scheme 100: Synthesis of tropolone analogue 559.
Scheme 101: Synthesis of tropolones 561 and 562.
Figure 35: o/p-Tropoquinone rings (563 and 564) and benzotropoquinones (565–567).
Scheme 102: Synthesis of benzotropoquinone 566.
Scheme 103: Synthesis of benzotropoquinone 567 via a Diels–Alder reaction.
Figure 36: Products 575–577 through 1,2,3-benzotropoquinone hydrate 569.
Scheme 104: Structures 578–582 prepared from tropoquinone 567.
Figure 37: Two possible structures 583 and 584 for dibenzotropoquinone, and precursor compound 585 for 583.
Scheme 105: Synthesis of saddle-shaped ketone 592 using dibenzotropoquinone 584.
Useful access to enantiomerically pure protected inositols from carbohydrates: the aldohexos-5-uloses route
- Felicia D’Andrea,
- Giorgio Catelani,
- Lorenzo Guazzelli and
- Venerando Pistarà
Beilstein J. Org. Chem. 2016, 12, 2343–2350, doi:10.3762/bjoc.12.227
- stereoseries, allowed for the rationalisation of a mechanism of the reaction based on open-transition-state models and electron-withdrawing inductive effects. Complementary reductions of the intermediate inososes were possible by changing the reaction conditions, and two isomeric inositol derivatives were
- obtained with complete stereoselection from each inosose. The presented approach permits us to control the configuration of three out of the six stereocentres of the inositol frame and gives access to seven of the nine inositols. Noteworthy, for the D-xylo derivative, the two-step sequence (condensation
- followed by reduction with NaBH(OAc)3) represents the biomimetic synthesis of myo-inositol. Furthermore, the sugar-based pathway leads directly to enantiomerically pure selectively protected inositols and does not require any desymmetrisation procedure which is needed when myo-inositol and other achiral
Graphical Abstract
Figure 1: Stereoisomeric inositols.
Scheme 1: Retrosynthetic approach to inositols from aldohexos-5-uloses.
Figure 2: Hypothesis of the preferred transition state.
Figure 3: Stereoselective reduction of inosose intermediate.
Scheme 2: Intramolecular cyclization of an orthogonally protected L-lyxo-aldohexos-5-ulose derivative.
Recent advances in N-heterocyclic carbene (NHC)-catalysed benzoin reactions
- Rajeev S. Menon,
- Akkattu T. Biju and
- Vijay Nair
Beilstein J. Org. Chem. 2016, 12, 444–461, doi:10.3762/bjoc.12.47
- - and galacto-configured dialdehydes 66 were promoted by the triazolium carbene precatalyst 22 to produce single inosose stereoisomers 67 in high yields (Scheme 40) [57]. Stereospecific reduction and deprotection of the inosose derivatives furnished allo- and epi-inositol in good yields. The camphor
Graphical Abstract
Scheme 1: Breslow’s proposal on the mechanism of the benzoin condensation.
Scheme 2: Imidazolium carbene-catalysed homo-benzoin condensation.
Scheme 3: Homo-benzoin condensation in aqueous medium.
Scheme 4: Homobenzoin condensation catalysed by bis(benzimidazolium) salt 8.
Scheme 5: List of assorted chiral NHC-catalysts used for asymmetric homobenzoin condensation.
Scheme 6: A rigid bicyclic triazole precatalyst 15 in an efficient enantioselective benzoin reaction.
Scheme 7: Inoue’s report of cross-benzoin reactions.
Scheme 8: Cross-benzoin reactions catalysed by thiazolium salt 17.
Scheme 9: Catalyst-controlled divergence in cross-benzoin reactions.
Scheme 10: Chemoselective cross-benzoin reactions catalysed by a bulky NHC.
Scheme 11: Selective intermolecular cross-benzoin condensation reactions of aromatic and aliphatic aldehydes.
Scheme 12: Chemoselective cross-benzoin reaction of aliphatic and aromatic aldehydes.
Scheme 13: Cross-benzoin reactions of trifluoromethyl ketones developed by Enders.
Scheme 14: Cross-benzoin reactions of aldehydes and α-ketoesters.
Scheme 15: Enantioselective cross-benzoin reactions of aliphatic aldehydes and α-ketoesters.
Scheme 16: Dynamic kinetic resolution of β-halo-α-ketoesters via cross-benzoin reaction.
Scheme 17: Enantioselective benzoin reaction of aldehydes and alkynones.
Scheme 18: Aza-benzoin reaction of aldehydes and acylimines.
Scheme 19: NHC-catalysed diastereoselective synthesis of cis-2-amino 3-hydroxyindanones.
Scheme 20: Cross-aza-benzoin reactions of aldehydes with aromatic imines.
Scheme 21: Enantioselective cross aza-benzoin reaction of aliphatic aldehydes with N-Boc-imines.
Scheme 22: Chemoselective cross aza-benzoin reaction of aldehydes with N-PMP-imino esters.
Scheme 23: NHC-catalysed coupling reaction of acylsilanes with imines.
Scheme 24: Thiazolium salt-mediated enantioselective cross-aza-benzoin reaction.
Scheme 25: Aza-benzoin reaction of enals with activated ketimines.
Scheme 26: Isatin derived ketimines as electrophiles in cross aza-benzoin reaction with enals.
Scheme 27: Aza-benzoin reaction of aldehydes and phosphinoylimines catalysed by the BAC-carbene.
Scheme 28: Nitrosoarenes as the electrophilic component in benzoin-initiated cascade reaction.
Scheme 29: One-pot synthesis of hydroxamic esters via aza-benzoin reaction.
Scheme 30: Cookson and Lane’s report of intramolecular benzoin condensation.
Scheme 31: Intramolecular cross-benzoin condensation between aldehyde and ketone moieties.
Scheme 32: Intramolecular crossed aldehyde-ketone benzoin reactions.
Scheme 33: Enantioselective intramolecular crossed aldehyde-ketone benzoin reaction.
Scheme 34: Chromanone synthesis via enantioselective intramolecular cross-benzoin reaction.
Scheme 35: Intramolecular cross-benzoin reaction of chalcones.
Scheme 36: Synthesis of bicyclic tertiary alcohols by intramolecular benzoin reaction.
Scheme 37: A multicatalytic Michael–benzoin cascade process for cyclopentanone synthesis.
Scheme 38: Enamine-NHC dual-catalytic, Michael–benzoin cascade reaction.
Scheme 39: Iminium-cross-benzoin cascade reaction of enals and β-oxo sulfones.
Scheme 40: Intramolecular benzoin condensation of carbohydrate-derived dialdehydes.
Scheme 41: Enantioselective intramolecular benzoin reactions of N-tethered keto-aldehydes.
Scheme 42: Asymmetric cross-benzoin reactions promoted by camphor-derived catalysts.
Scheme 43: NHC-Brønsted base co-catalysis in a benzoin–Michael–Michael cascade.
Scheme 44: Divergent catalytic dimerization of 2-formylcinnamates.
Scheme 45: One-pot, multicatalytic asymmetric synthesis of tetrahydrocarbazole derivatives.
Scheme 46: NHC-chiral secondary amine co-catalysis for the synthesis of complex spirocyclic scaffolds.
Diastereoselective synthesis of new O-alkylated and C-branched inositols and their corresponding fluoro analogues
- Charlotte Collet,
- Françoise Chrétien,
- Yves Chapleur and
- Sandrine Lamandé-Langle
Beilstein J. Org. Chem. 2016, 12, 353–361, doi:10.3762/bjoc.12.39
- -alkylated and C-branched inositols and their corresponding fluoro analogues. The key steps of the synthesis were the easy accessibility of different types of arms in term of configuration (myo and scyllo), the linking method and length, which could modulate the biological properties. These inositol
- ; Introduction Inositol is a trivial name used to describe cyclohexanehexol compounds. Nine stereoisomers exist differing in the relative orientation of the hydroxy groups, the most naturally abounding and biologically important is myo-inositol [1][2]. The chemistry of inositols has been the theme of several
- investigations in the past few years [3][4]. Indeed inositols and their phosphorylated or glycosylated [5] derivatives are involved in various biological processes [6][7][8][9][10][11][12][13][14][15][16][17][18][19]. In recent years, studies have shown that inositol derivatives interact with the β-amyloid
Graphical Abstract
Figure 1: Structures of targeted synthetic inositol derivatives.
Scheme 1: Synthesis of O-alkylated inositol derivatives 1. Reagents and conditions: a) NaBH4, iPrOH, rt, 2 h,...
Scheme 2: Synthesis of O-alkylated fluorinated inositol derivatives 2.
Scheme 3: Synthesis of C-alkenylated inositol intermediates.
Figure 2: nOe correlations for C-alkenylated inositol intermediates.
Scheme 4: Synthesis of C-branched inositol derivatives 3 and 4.
Scheme 5: Synthesis of C-branched fluorinated inositol derivatives 5. Reagents and conditions: a) TrCl, DMAP ...
Scheme 6: Synthesis of C-branched fluorinated inositol derivatives 6. Reagents and conditions: a) TrCl, DMAP ...
Mycothiol synthesis by an anomerization reaction through endocyclic cleavage
- Shino Manabe and
- Yukishige Ito
Beilstein J. Org. Chem. 2016, 12, 328–333, doi:10.3762/bjoc.12.35
- anomerization reaction from an easily prepared β-aminoglycoside through endocyclic cleavage. Keywords: anomerization; aminoglycoside; endocyclic cleavage reaction; inositol; mycothiol; Introduction Tuberculosis is an infectious disease and has had a high death rate over the past few decades [1][2][3][4]. The
- Streptomycetes [5][6][7][8][9][10]. It consists of an N-acetylcysteine, a D-glucosamine, and a D-myo-inositol moiety (Figure 1). D-Glucosamine is α-linked to D-myo-inositol at the 1-position, and N-acetylcysteine is linked to the amino group of D-glucosamine. The conformation of MSH has been investigated by NMR
- Gram-negative bacteria. MSH undergoes metal-catalyzed autoxidation more rapidly than glutathione [16]. The biosynthetic pathway of MSH has been well investigated; MSH is synthesized from 1-inositol phosphate and uridine diphosphate N-acetylglucosamine (UDP-GlcNAc) in five steps [15]. It is used by
Graphical Abstract
Figure 1: Structure of mycothiol 1.
Scheme 1: Detoxification pathway mediated by MSH.
Scheme 2: Anomerization via endocyclic cleavage.
Scheme 3: Outline of mycothiol synthesis by anomerization.
Scheme 4: Synthesis of a pseudodisaccharide by an anomerization reaction.
Scheme 5: Mycothiol synthesis from pseudo-disaccharide 4.
Synthesis of the calcilytic ligand NPS 2143
- Henrik Johansson,
- Thomas Cailly,
- Alex Rojas Bie Thomsen,
- Hans Bräuner-Osborne and
- Daniel Sejer Pedersen
Beilstein J. Org. Chem. 2013, 9, 1383–1387, doi:10.3762/bjoc.9.154
- was performed as previously described [20]. (R)-3 showed inhibition of calcium-stimulated D-myo-inositol monophosphate (IP1) accumulation in a concentration-dependent manner, with a potency consistent with that reported in the literature [21][22] (IC50 = 0.64 μM, pIC50 = 6.3 ± 0.2), thus confirming
Graphical Abstract
Figure 1: Marketed calcium-sensing receptor agonist cinacalcet (1), and CaSR antagonists Calhex 231 (2) and N...
Scheme 1: Strategy for assembling (R)-3 from fragments 4, 5 and 6. m-Ns = m-nitrobenzenesulfonyl.
Scheme 2: Synthesis of amine building block 6 by using Katritzky’s pyrylium chemistry [16].
Scheme 3: Synthesis of phenol 4 from commercially available aryl fluoride 13.
Scheme 4: Synthesis of rac-3 and (R)-3 from commercially available racemic- and (S)-glycidol 15, respectively...
Figure 2: Determination of the optical purity for (R)-3 by chiral HPLC on a Daicel AD-H column. Top: Opticall...
Figure 3: Characterisation of concentration-dependent (R)-3 inhibition of 3.5 mM calcium-stimulated IP1 respo...
Branching out at C-2 of septanosides. Synthesis of 2-deoxy-2-C-alkyl/aryl septanosides from a bromo-oxepine
- Supriya Dey and
- Narayanaswamy Jayaraman
Beilstein J. Org. Chem. 2012, 8, 522–527, doi:10.3762/bjoc.8.59
- metathesis reactions of appropriately installed diene derivatives [11][12][13]; (iv) ring expansion of 1,2-cyclopropanated sugars [14][15][16][17]; (v) Baeyer–Villiger oxidation of inositol derivatives [18][19] and (vi) electrophile-induced cyclization [20]. We recently developed a new methodology to prepare
Graphical Abstract
Figure 1: Synthetic route to transform oxyglycal I to a septanoside V.
Scheme 1: Reaction conditions: (i) NaOMe, PhMe, reflux, 8 h; (ii) methyl acrylate (for 3); tert-butyl acrylat...
Scheme 2: Reaction conditions: (i) phenylboronic acid (for 8); 4-methoxyphenylboronic acid (for 9); 3-methylp...
Scheme 3: Reaction conditions: (i) phenylacetylene (for 11); oct-1-yne (for 12); Pd(PPh3)2Cl2 (20 mol %), CuI...
Scheme 4: Reaction conditions: (i) Pd/C (10 %), H2, MeOH, rt, 24 h; (ii) NaBH4, MeOH, 0 °C to rt, 3 h.
Synthesis of glycoconjugate fragments of mycobacterial phosphatidylinositol mannosides and lipomannan
- Benjamin Cao,
- Jonathan M. White and
- Spencer J. Williams
Beilstein J. Org. Chem. 2011, 7, 369–377, doi:10.3762/bjoc.7.47
- biosynthesis commences with the stepwise transfer of two mannosyl residues onto inositol, catalyzed by the GDP-mannose dependent α-mannosyltransferases PimA [11] and PimB' [12][13], followed by acylation by the acyltransferase (Rv2611c) to give AcPIM2 [14][15]. Additional α-1,6-mannosylations of AcPIM2 give
- arabinan to the penultimate mannose residue of LM, and is subsequently capped with a variety of groups including inositol phosphate, 5-methylthioxylose and its sulfoxide, and short 1,2-mannose oligomers [7]. Studies into the biosynthesis of the PIMs, LM and LAM have been greatly facilitated by the
- crystal X-ray determination of (7S)-18. Thermal ellipsoids denote 20% electron probability. Indicative topology model for the biosynthesis of the glycophospholipids PIMs, LM and LAM in mycobacteria. The timing for translocation of PIM intermediates across the membrane is unclear. Hexagon = myo-inositol
Graphical Abstract
Scheme 1: Indicative topology model for the biosynthesis of the glycophospholipids PIMs, LM and LAM in mycoba...
Figure 1: Chemical structures of (A) a representative PIM, AcPIM5 and (B) a mannan fragment of LM from mycoba...
Figure 2: Target di- and trisaccharide glycoconjugate fragments of PIMs and LM.
Scheme 2: Synthesis of azidooctyl alcohol 14 and diol 15.
Scheme 3: Synthesis of mannosyl donors 16 and 17.
Figure 3: ORTEP plot of single crystal X-ray determination of (7S)-18. Thermal ellipsoids denote 20% electron...
Scheme 4: Synthesis of disaccharide 1 and trisaccharide 2.
Scheme 5: Synthesis of trisaccharide 3.
Scheme 6: Synthesis of trisaccharide 4.
Scheme 7: Synthesis of glycoconjugates 5–7 and 8–10.
Design and synthesis of a cyclitol-derived scaffold with axial pyridyl appendages and its encapsulation of the silver(I) cation
- Pierre-Marc Léo,
- Christophe Morin and
- Christian Philouze
Beilstein J. Org. Chem. 2010, 6, 1022–1024, doi:10.3762/bjoc.6.115
- Pierre-Marc Leo Christophe Morin Christian Philouze Département de Chimie Moléculaire (CNRS, UMR 5250, ICMG FR-2607) Université Joseph Fourier, 301 Rue de la Chimie, 38402 Grenoble Cedex, France 10.3762/bjoc.6.115 Abstract Conversion of a myo-inositol derivative into a scyllo-inositol-derived
- scaffold with C3v symmetry bearing three axial pyridyl appendages is presented. This pre-organized hexadentate ligand allows complexation of silver(I). The crystal structure of the complex was established. Keywords: cyclitol; glyco-scaffolds; hexadentate; scyllo-inositol; silver(I) complexation
- this work the synthesis of an cyclitol-derived scaffold designed to sequester Ag is presented. Interaction of myo-inositol-derived podands [6] and crown ethers [7] with Ag salts has been shown to depend on the relative spatial orientation of the binding sites moreover, in mono-orthoesters of scyllo
Graphical Abstract
Figure 1: spatial representation of structure 1.
Figure 2: structures of compounds 2–9.
Figure 3: ORTEP drawing for the 1·Ag(I) cation complex (ellipsoids are drawn at the 50% probability level and...
